What is Petulant BPD? Understanding the Symptoms, Causes, and Management

We’re honored to share that Advancements with Ted Danson recently spotlighted Amae Health’s work in transforming mental health care for people with severe mental illness (SMI). This episode offers an inside look into our unique, outcome-driven approach that combines technology and compassionate care to support our members’ journeys toward lasting stability and a higher quality of life.

At Amae, we’re dedicated to providing more than just treatment. Our approach includes personalized therapy, medical support, lifestyle guidance, and a strong community connection. We’re committed to creating spaces where healing and growth are possible.

Catch the full story on Amazon Prime Video, Advancements Season 3, Episode 9, to see how we’re helping those who need it most.

A schizophrenia diagnosis arrives to a person in a small room, and rearranges things without asking — the way a conversation feels, the way a plan for next year suddenly needs rewriting, the way someone you love looks at you and you can't quite tell what they're thinking anymore. Most of what you'll read about schizophrenia treatment options is either clinical to the point of cold, or optimistic in a way that skips the hard parts. 

Schizophrenia is a chronic condition. In 2026, it is also named one of the most treatable severe mental illnesses in psychiatry. The medications have quietly changed over the last two years, with the care models changing even faster. And the question clinicians now ask (is this person living a life they recognize as their own?) is a better question than the one psychiatry asked a generation ago.

This is a guide to what schizophrenia treatment actually looks like now.

What "Treatment" Means for Schizophrenia in 2026

For most of psychiatry's history, treating schizophrenia meant turning down the volume on hallucinations and delusions and hoping everything else would hold. Consequently, it often didn't. The older medications were blunt instruments — they could quiet the psychosis while leaving a person sedated, emotionally flat, and unable to concentrate. A patient could be symptom-free on paper and still lose their apartment, their job, and their social world, not because the illness had won, but because the treatment had taken too much with it.

That old goal has been replaced.

The modern target is functional recovery: the ability to live a connected, productive life, be it work or school. Rebuilding the relationships that came apart during the acute phase. Living on your own terms. Functional recovery is not the same as symptom elimination. Some of the people who reach it still hear voices, and some of the people with zero symptoms can't hold a routine. What functional recovery actually requires, almost without exception, is a care plan that treats medication, therapy, physical health, and social support as one whole problem instead of four.

Pharmacological Breakthroughs: A New Era of Medication

Medication is the floor of schizophrenia treatment, not the ceiling. For about 40 years, that floor was built of one material: antipsychotics that bind dopamine D2 receptors and block the signal. That is still the starting point for most patients in 2026. What has quietly changed is the field, which now has options that were not there two years ago.

Second-Generation Antipsychotics: The Current Standard

Risperidone, olanzapine, aripiprazole, paliperidone, quetiapine. Those are the names that will likely appear first in any conversation with a psychiatrist. They're called "second-generation" or "atypical" antipsychotics because together, they work on dopamine and serotonin, producing a more favorable profile for negative symptoms and cognitive effects than the drugs that came before them.

They work. They also come at a cost.

The trade-off is metabolic. Weight gain. Elevated blood sugar. Shifts in lipid panels that, untracked, add up to real cardiovascular risk over time. A care team that prescribes these medications without monitoring the body is doing half the job. Metabolic monitoring is not optional.

The Non-Dopaminergic Revolution: Cobenfy and Muscarinic Agonists

In September 2024, something happened in schizophrenia pharmacology for the first time in about 35 years. The FDA approved xanomeline-trospium (Cobenfy, formerly known as KarXT), and the mechanism was not a variation on the dopamine theme. Cobenfy works on muscarinic receptors (specifically the M1 and M4 subtypes), meaning the biological pathway it acts on is different in kind, not just in detail (Yale Medicine).

Here is why that matters.

Roughly one-third of patients don't respond adequately to dopamine-based medications. The metabolic and movement-related side effects of the older drugs are also downstream of dopamine blockade. Cobenfy doesn't block dopamine, which is why early trials suggest it may avoid some of that side effect profile.

Long-term data is still accumulating. For now, the field has its first new mechanism in a generation.

Long-Acting Injectables: Reducing the Daily Burden

Long-acting injectable antipsychotics, or LAIs, deliver a single dose that lasts weeks or even months. For patients whose relapses have traced back to missed pills, that is a meaningful shift.

The evidence has caught up with the intuition. A 2022 network meta-analysis in World Psychiatry pooled 92 randomized trials and 22,645 participants and found that LAIs hold up against daily oral antipsychotics in preventing relapse (Ostuzzi et al., 2022). Real-world studies of US Medicare patients have shown LAIs are associated with lower rates of psychiatric hospitalization and treatment discontinuation.

LAIs are not right for every patient. Some people find meaning in the daily ritual of a pill. Some have had painful experiences with injections. The right answer comes out of a real conversation with a psychiatrist who has the patient's history in front of them.

Models of Care: Why the Environment Matters

The same medication can produce very different outcomes depending on how it is delivered. Two patients on the same dose of the same drug can end up in very different places a year later. The difference is usually the system around them.

Coordinated Specialty Care (CSC)

In 2026, coordinated Specialty Care is the standard for early psychosis.It is also one of the clearest examples in psychiatry of a care model producing better outcomes than a new drug would. The American Psychiatric Association formally endorsed it in its 2020 practice guideline (APA Practice Guideline for the Treatment of Patients With Schizophrenia), and it came out of the NIMH RAISE research initiative.

The model is a single team of clinicians working from one plan: medication management, individual therapy, supported employment and education, family education, and case management that actually happens, rather than getting sent to five different offices on five different days.

The data is strong. In the NIMH RAISE Early Treatment Program, patients who received CSC had hospitalization rates of 23% compared with 44% in usual community care (NIMH: Team-based Treatment is Better for First Episode Psychosis). They were also more likely to stay in school or employment and experienced greater improvement in symptoms, interpersonal relationships, and quality of life (Kane et al., American Journal of Psychiatry, 2016).

That is a halving of hospitalization risk, produced by a care model rather than a new molecule.

CSC was built for early psychosis. For patients further along in treatment, other models fit better.

Integrated Outpatient Care for Severe Mental Illness

For patients past the first-episode window, integrated outpatient care takes the same principle as CSC and adapts it for the long haul. The model brings psychiatrists, therapists, primary care physicians, dietitians, health coaches, peer mentors, and clinical care coordinators under one roof, working from a single shared plan.

The problem it solves is fragmentation. In the usual picture, a patient has a psychiatrist at one office, a therapist at another, a primary care provider at a third, and if case management exists at all, it runs on lost email attachments. Small things become crises. Crises become hospitalizations. Hospitalizations become the next relapse.

But it doesn't have to work that way.

This is the model our integrated outpatient clinics are built on. We see adults 18 and older. Our care team is designed so that mental health, physical health, and everyday function are handled in the same place, by people who talk to each other. The patient is not the one running the coordination.

Crisis Services and Long-Term Stability

Crisis services are not long-term care, and long-term care is not crisis services. Inpatient hospitalization exists to keep people safe when symptoms are acute. It is essential, and it saves lives. But it is not designed to produce long-term stability, and the handoff from inpatient to outpatient is the highest-risk period for readmission. That handoff is where integrated outpatient care earns its keep.

Evidence-Based Psychosocial Interventions

Medication does one job well. It quiets the biology. Everything else is outside what a pill can do: how a person thinks about what is happening to them, how they rebuild relationships that came apart during the acute phase, how they get back into work or school.

That is where psychosocial interventions come in.

Cognitive Behavioral Therapy for Psychosis (CBTp)

CBT for Psychosis, usually shortened to CBTp, is not standard CBT with a few tweaks. It is a specialized protocol built from the ground up for people who hear voices, hold persistent unusual beliefs, or are trying to function while symptoms are still present. The APA practice guideline gives CBTp a 1B rating, which translates roughly to "the evidence is strong and clinicians should offer this" (APA Practice Guideline, 2020).

What CBTp actually does in a session is teach specific skills. Reality testing. Cognitive distancing from distressing voices. Stress-reduction techniques for the moments when symptoms spike. Coping strategies for persistent delusions that have not responded fully to medication. The goal is not to eliminate the symptoms. It is to change the relationship a person has with them.

Social Skills and Vocational Training

Skills erode during acute episodes. A patient who was holding a job six months ago and had friends two years ago can come back from a hospitalization and find that the conversational rhythm, the workplace reflexes, and the social scaffolding are all gone. Not permanently. Just not where they left them.

Structured social skills training is what it sounds like: deliberate practice. Starting conversations. Reading a room at work. Managing conflict without escalation. Re-entering relationships that went quiet during the acute phase. Supported employment programs pair these skills with real job coaching, and the evidence is that they help people get and keep work when traditional vocational rehabilitation has not.

Cognitive Remediation

Hallucinations and mood can stabilize while the harder, quieter symptoms persist: forgetting appointments, losing the thread of a conversation, struggling to plan a week. These are the symptoms that sit between "stable" and "back to a life I recognize." For many patients, they are what actually prevents the return to work or school.

Cognitive remediation is structured training for those skills. Memory exercises. Attention work. Executive function practice. The programs are not new, but they are one of the most underprescribed interventions in this space. They will not cure cognitive symptoms, but they can meaningfully improve day-to-day function.

The Role of Family and Community Support

No one recovers from schizophrenia alone. That is not a sentimental claim, but a finding that has been reproduced in study after study over several decades.

Family psychoeducation is one of the most consistently supported non-medication interventions in the books. The idea is simple: when the people a patient lives with understand what schizophrenia is, what the medications do, and how to communicate in hard moments, relapse rates drop. A concept in the research called "expressed emotion" describes a household climate marked by high levels of criticism, hostility, or emotional over-involvement. When that climate softens, relapse rates soften with it. Nothing about this says families cause schizophrenia. They don't. But the environment in which treatment either catches or slips is incredibly important.

Community reintegration carries the same weight. A stable apartment. A part-time job, even a small one. Peer support groups. A faith community if that fits. Friendships that survive the acute phase. These are not "lifestyle" factors that sit outside treatment. They are the treatment. A patient with housing and a routine has a very different clinical trajectory from the same patient without them.

How to Choose Among Schizophrenia Treatment Options

The question families ask us is almost never "should we get treatment." It is "how do we pick the right place." A few things matter more than the rest in that decision.

Start with the intake. A good assessment is not a form that takes 20 minutes to fill out. It is a conversation that covers psychiatric history, medication history and response, current symptoms, physical health, substance use, the home situation, and what the patient actually wants out of treatment. If the intake is structured as a checklist, the treatment plan will be too.

Ask how the team communicates. Is there a dedicated case manager? Does the psychiatrist read the therapist's notes? Is metabolic monitoring built into the schedule? Is family involvement standard? Are outcomes tracked? These are the questions we built our care model to answer, and a clinic that stumbles on them is worth a second look.

Insist on shared decision-making. A patient is a participant in their treatment, not a recipient of it. A good clinician lays out the trade-offs of each medication in plain language, listens to what the patient wants, and makes decisions alongside them. A clinician who rushes that or waves it off is telling you something.

Frequently Asked Questions

Q: Can schizophrenia be cured?

Not cured in the traditional sense. Schizophrenia is managed, which is a word that sounds smaller than it is. "Managed" in 2026 can mean living for decades with minimal disruption, working, keeping relationships, and needing medical care the way a person with diabetes does. Functional recovery is achievable for a meaningful number of patients, though not all.

Q: What happens if I stop taking my medication?

The risk of relapse rises sharply. What makes stopping tricky is the delay. Many people who discontinue antipsychotic medication feel fine for weeks, sometimes months, before symptoms return. That gap is long enough to conclude the medication wasn't necessary, and then to be caught off guard when symptoms do come back. Talk to your prescriber before making any changes.

Q: Are there natural treatments for schizophrenia?

Sleep, exercise, nutrition, and stress management support mental health and matter for anyone living with schizophrenia. They are not a substitute for medical treatment. If something is marketed as a "natural cure" for schizophrenia, that is a reason to stop reading. Supplements, herbs, and alternative therapies have not been shown to treat the underlying biology of the condition. Some interact with prescribed medications in ways that can be dangerous.

Q: How do I help a loved one who refuses treatment?

This is the question we hear most from families, and it is the hardest one. A few things help:

• Anosognosia, a lack of awareness of one's illness, is itself a symptom of schizophrenia. It is not denial. Understanding the difference can change how you approach the conversation.
• The LEAP method (Listen, Empathize, Agree, Partner), developed by Dr. Xavier Amador, was built for exactly these situations.
• NAMI's Family-to-Family programs teach communication skills and connect families with others walking the same path.
• In an acute safety crisis, call 988, the Suicide and Crisis Lifeline, or your local mobile crisis team.

Moving Toward Functional Recovery

A schizophrenia diagnosis is a serious event. It is not a verdict.

The range of schizophrenia treatment options has meaningfully widened since 2024. New medications. New evidence about old medications. Care models with strong outcomes data. Psychosocial interventions that help with the parts of recovery medication cannot touch. The clinical goal has moved from quieting the biology to helping a person live a life they recognize as their own.

What most patients and families need is not a single treatment.

They need a team that treats the whole picture, which means symptoms, physical health, relationships, work, and function, as one problem instead of four.

If you or someone you love is living with schizophrenia, schizoaffective disorder, or a related condition, Amae Health is here to talk. Our care teams include psychiatrists, therapists, primary care providers, dietitians, health coaches, peer mentors, and clinical care coordinators, all working from one shared plan. We see adults 18 and older at our clinics in Los Angeles, Los Altos, San Mateo, Raleigh, New York, and Brooklyn. To start the conversation, call 1-888-860-2825 or request an intake appointment.

‍

Citations

1. 3 Things to Know About Cobenfy, Yale Medicine. Tier 4 (major academic medical center).
2. Ostuzzi et al., "Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants," World Psychiatry, 2022. Tier 1 (peer-reviewed).
3. Kane et al., "Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program," American Journal of Psychiatry, 2016. Tier 1 (peer-reviewed).
4. NIMH: Team-based Treatment is Better for First Episode Psychosis. Tier 2 (government).

The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, 2020. Tier 3 (professional association).

Attention-seeking behavior are ways individuals express their need for connection, validation, or reassurance. Such behavior can manifest in different ways, from exaggerated emotionality and dramatization of events to provocative statements or unusual dress.

To a greater or lesser extent, attention-seeking behavior is inherent in all people. It is a natural part of human nature. We are all social beings; recognition and acceptance are basic psychological needs. However, the intensity of this need varies considerably depending on age and life circumstances.

In children, attention-seeking behavior is a normal stage of development. Babies may cry loudly, become cranky, or throw tantrums. This is their way of trying to get their parent's attention. As they grow older, most people learn to get the attention they need in socially acceptable ways. However, in times of stress or uncertainty, even adults may resort to more overt forms of attention-seeking.

During adolescence, attention-seeking often intensifies. This is due to identity formation and increased sensitivity to peer opinion. In adulthood, this behavior usually becomes more restrained. But, it can become more active during life crises or when social interaction is lacking.

Is Attention-Seeking Behavior a Sign of a Disorder?

It is essential to distinguish between normal attention-seeking behavior and pathological attention-seeking behavior. Typical behavior of this kind:

• Is situational and not persistent
• Does not significantly disrupt daily life and relationships
• The person is usually aware of their motives
• Does not cause significant distress to the person or others.

Pathological attention-seeking behavior, on the other hand, is characterized by:

• Persistent and compulsive
• Serious impairment of social and professional functioning
• Inability to control impulses
• Extreme distress at not receiving the desired attention
• Willingness to take extreme measures to get attention

Associated Mental Health Disorders

Excessive attention-seeking can be a symptom of a variety of mental disorders:

• Histrionic personality disorder. This problem is characterized by excessive emotionality, theatricality, and constant attention-seeking. People with this disorder often dramatize events. They may use provocative behavior and seek to be the center of attention.
• Borderline personality disorder. It can also manifest itself in intense attention-seeking behavior, often associated with fear of loneliness and abandonment.
• Narcissistic personality disorder. In this problem, attention-seeking is accompanied by a grandiose sense of self and a need for constant admiration.
• Anxiety disorders. These sometimes manifest themselves through attention-seeking behavior to gain validation and reassurance.
• Bipolar disorder. This problem during manic episodes may be accompanied by increased attention-seeking behavior.
• Oppositional-defiant disorder. In children and adolescents, oppositional defiant disorder often manifests itself through attention-seeking behavior, including deliberate rule-breaking.

What Drives People to Seek Attention?

The origins of attention-seeking are diverse and may have several factors:

Psychological factors:

• Low self-esteem and the need for external validation of one's worth
• Feelings of insecurity and lack of recognition
• Unmet need for intimacy and acceptance

Social factors:

• Cultural norms that encourage individualism and social visibility
• A competitive environment where attention means success
• Modeling the behavior of significant others

Environmental factors:

• Childhood experiences, especially if parental attention was inconsistent or conditioned
• Traumatic experiences that create a need for validation and safety
• The influence of social media, where attention is measured by likes and followers

Neurobiological studies show that receiving social attention activates the reward system in the brain. This triggers the release of dopamine, a neurotransmitter associated with pleasure and habit formation. This explains why attention-seeking can become self-reinforcing.

With social media, seeking attention has become easier than ever, sometimes turning likes and shares into a measure of self-worth. At Amae Health, we understand that attention-seeking behaviors often stem from deeper emotional needs. Our approach focuses on helping individuals identify these underlying factors and develop healthier ways to seek connection.

Attention-Seeking vs. Histrionic Personality Disorder

Differentiating Between the Two

Although attention-seeking is a key component of histrionic personality disorder, these concepts are not identical.

Attention seeking can be:

• A temporary state in response to certain circumstances
• Part of a normal behavioral repertoire
• Moderate and not significantly problematic
• Recognized and controlled

Histrionic personality disorder is a persistent pattern of internal experience and behavior that:

• Is present continuously rather than situationally
• Appears in all areas of life
• Causes significant difficulties in social adjustment
• It is accompanied by symptoms other than attention seeking.

Diagnostic Criteria for HPD

According to the DSM-5, histrionic personality disorder is diagnosed when at least five of the following criteria are present:

• Discomfort in situations where the person is not the center of attention
• Interactions with others are often characterized by inappropriate, sexually seductive, or provocative behavior
• Rapidly changing and superficial expressions of emotion
• Constant use of appearance to attract attention
• Speech is overly impressionistic and lacking in detail
• Demonstrative, theatrical, and exaggerated expression of emotion
• Suggestibility, easily influenced by other people or circumstances
• Perceiving relationships as more intimate than they really are

Impacts of Attention-Seeking Behavior

Attention-seeking behavior can seriously affect personal relationships:

• Create emotional strain on partners and significant others
• Cause feelings of manipulation and exhaustion in others
• Lead to shallow and unstable relationships
• Create cycles of crisis and dramatic reconciliation.

With histrionic personality disorder, these problems are exacerbated, often leading to chronic difficulty in maintaining healthy relationships.

In work and academic environments, excessive attention-seeking can:

• Disrupt group dynamics and teamwork
• Create conflict and tension within the team
• Distract from tasks and reduce productivity
• Build a reputation as an unreliable or difficult employee

People with strong attention-seeking behaviors may have difficulty in environments that require restraint and focus on the outcome rather than the process.

Management and Treatment Approaches

Cognitive behavioral therapy (CBT) effectively works with attention-seeking behavior by helping to identify and change maladaptive thoughts and behavioral patterns.

Dialectical behavior therapy (DBT) is particularly useful for histrionic personality disorder, teaching skills in emotion regulation, interpersonal effectiveness, and distress tolerance.

Group therapy provides a safe environment in which to receive healthy feedback on the effects of attention-seeking behaviors on others.

For those seeking to manage their attention-seeking, helpful:

• Mindfulness techniques to help recognize impulses before they are realized
• Developing self-reflection skills to understand underlying needs
• Developing healthy ways of receiving affirmation and recognition
• Balancing the need for attention with respect for the boundaries of others

Amae Health offers comprehensive programs for working with attention-seeking behaviors, including individual and group therapy, as well as online self-help resources.

Final thoughts

Attention-seeking behavior is a multifaceted phenomenon that exists on a spectrum from normal to pathological. Understanding its causes and manifestations helps professionals and ordinary people balance healthy attention-seeking behavior and its destructive forms.

It is important to remember that excessive attention-seeking behavior often hides unmet emotional needs, and addressing these underlying issues is key to long-term change. Whether the problem is a temporary reaction to stress or a manifestation of histrionic personality disorder, modern approaches in psychology and psychotherapy offer effective strategies for help and support.

‍